AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.080
-0.210 (-9.17%)
At close: Nov 5, 2026, 4:00 PM EST
2.070
-0.010 (-0.48%)
After-hours: Nov 5, 2026, 4:54 PM EST

AC Immune Revenue

AC Immune had revenue of 3.24M CHF in the quarter ending September 30, 2026, with 245.47% growth. This brings the company's total for the last twelve months to 19.81M, up 353.20% year-over-year. In the year 2025, AC Immune had annual revenue of 3.57M, down -86.92%. That makes AC Immune the 32,786th largest company in the world by revenue and 4,313th in the United States.

Revenue (ttm)
19.81M CHF
Revenue Growth
+353.20%
P/S Ratio
8.79
Revenue / Employee
162,410 CHF
Employees
122
Market Cap
206.81M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.57M-23.74M-86.92%
Dec 31, 202427.31M12.51M84.51%
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.26M1,435.39%
Dec 31, 20187.19M-13.06M-64.48%
Dec 31, 201720.26M-2.96M-12.75%
Dec 31, 201623.21M-15.88M-40.61%
Dec 31, 201539.09M8.82M29.14%
Dec 31, 201430.27M21.63M250.46%
Dec 31, 20138.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.